nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0653	0.399	CbGeAlD
Mepivacaine—SCN8A—nerve—peripheral nervous system neoplasm	0.0206	0.126	CbGeAlD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.0148	0.0734	CbGpPWpGaD
Mepivacaine—SCN10A—nerve—peripheral nervous system neoplasm	0.0138	0.0842	CbGeAlD
Mepivacaine—SCN10A—ganglion—peripheral nervous system neoplasm	0.0136	0.0832	CbGeAlD
Mepivacaine—SCN8A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00961	0.0476	CbGpPWpGaD
Mepivacaine—SCN8A—brainstem—peripheral nervous system neoplasm	0.00885	0.054	CbGeAlD
Mepivacaine—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.00879	0.0537	CbGeAlD
Mepivacaine—SCN9A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00777	0.0385	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00743	0.0368	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00714	0.0354	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00714	0.0354	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00689	0.0341	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00689	0.0341	CbGpPWpGaD
Mepivacaine—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.00669	0.0409	CbGeAlD
Mepivacaine—SCN1A—brainstem—peripheral nervous system neoplasm	0.00669	0.0408	CbGeAlD
Mepivacaine—SCN2A—brainstem—peripheral nervous system neoplasm	0.00614	0.0375	CbGeAlD
Mepivacaine—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00484	0.024	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00474	0.0235	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00469	0.0232	CbGpPWpGaD
Mepivacaine—SCN8A—cerebellum—peripheral nervous system neoplasm	0.00437	0.0266	CbGeAlD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.0038	0.0188	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00379	0.0188	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00363	0.018	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00363	0.018	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00349	0.0173	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00349	0.0173	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00336	0.0167	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00336	0.0167	CbGpPWpGaD
Mepivacaine—SCN1A—cerebellum—peripheral nervous system neoplasm	0.0033	0.0201	CbGeAlD
Mepivacaine—SCN2A—cerebellum—peripheral nervous system neoplasm	0.00303	0.0185	CbGeAlD
Mepivacaine—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00294	0.0145	CbGpPWpGaD
Mepivacaine—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00283	0.00447	CcSEcCtD
Mepivacaine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00283	0.00446	CcSEcCtD
Mepivacaine—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.00282	0.00445	CcSEcCtD
Mepivacaine—Back pain—Tretinoin—peripheral nervous system neoplasm	0.00282	0.00445	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00281	0.0139	CbGpPWpGaD
Mepivacaine—Ventricular arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00277	0.00436	CcSEcCtD
Mepivacaine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00275	0.00434	CcSEcCtD
Mepivacaine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00275	0.00434	CcSEcCtD
Mepivacaine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00273	0.00431	CcSEcCtD
Mepivacaine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00273	0.00431	CcSEcCtD
Mepivacaine—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.00273	0.0043	CcSEcCtD
Mepivacaine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00271	0.00428	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.0027	0.0134	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.0027	0.0134	CbGpPWpGaD
Mepivacaine—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00269	0.00424	CcSEcCtD
Mepivacaine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00268	0.00423	CcSEcCtD
Mepivacaine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00268	0.00423	CcSEcCtD
Mepivacaine—SCN3A—cerebellum—peripheral nervous system neoplasm	0.00266	0.0162	CbGeAlD
Mepivacaine—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00263	0.00415	CcSEcCtD
Mepivacaine—Syncope—Tretinoin—peripheral nervous system neoplasm	0.00262	0.00413	CcSEcCtD
Mepivacaine—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.00262	0.00413	CcSEcCtD
Mepivacaine—Sweating—Vincristine—peripheral nervous system neoplasm	0.00261	0.00412	CcSEcCtD
Mepivacaine—SCN1A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.0026	0.0129	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.0026	0.0129	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00259	0.0128	CbGpPWpGaD
Mepivacaine—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00257	0.00404	CcSEcCtD
Mepivacaine—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.00404	CcSEcCtD
Mepivacaine—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00399	CcSEcCtD
Mepivacaine—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00399	CcSEcCtD
Mepivacaine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00252	0.00397	CcSEcCtD
Mepivacaine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00252	0.00397	CcSEcCtD
Mepivacaine—Convulsion—Melphalan—peripheral nervous system neoplasm	0.0025	0.00393	CcSEcCtD
Mepivacaine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00248	0.0039	CcSEcCtD
Mepivacaine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.0039	CcSEcCtD
Mepivacaine—Chills—Dactinomycin—peripheral nervous system neoplasm	0.00246	0.00388	CcSEcCtD
Mepivacaine—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00241	0.00381	CcSEcCtD
Mepivacaine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.0024	0.00379	CcSEcCtD
Mepivacaine—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00239	0.00376	CcSEcCtD
Mepivacaine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00238	0.00376	CcSEcCtD
Mepivacaine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00238	0.00376	CcSEcCtD
Mepivacaine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00238	0.00376	CcSEcCtD
Mepivacaine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00238	0.00376	CcSEcCtD
Mepivacaine—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00237	0.00373	CcSEcCtD
Mepivacaine—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00236	0.0117	CbGpPWpGaD
Mepivacaine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00235	0.00371	CcSEcCtD
Mepivacaine—Oedema—Melphalan—peripheral nervous system neoplasm	0.00235	0.00371	CcSEcCtD
Mepivacaine—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.00369	CcSEcCtD
Mepivacaine—Shock—Tretinoin—peripheral nervous system neoplasm	0.00234	0.00369	CcSEcCtD
Mepivacaine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00366	CcSEcCtD
Mepivacaine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00366	CcSEcCtD
Mepivacaine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00232	0.00366	CcSEcCtD
Mepivacaine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.0023	0.00363	CcSEcCtD
Mepivacaine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.0023	0.00363	CcSEcCtD
Mepivacaine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00229	0.00362	CcSEcCtD
Mepivacaine—Atrioventricular block—Epirubicin—peripheral nervous system neoplasm	0.00228	0.0036	CcSEcCtD
Mepivacaine—Chills—Alitretinoin—peripheral nervous system neoplasm	0.00228	0.00359	CcSEcCtD
Mepivacaine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.00351	CcSEcCtD
Mepivacaine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00223	0.00351	CcSEcCtD
Mepivacaine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00349	CcSEcCtD
Mepivacaine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.0022	0.00347	CcSEcCtD
Mepivacaine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.0022	0.00346	CcSEcCtD
Mepivacaine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00342	CcSEcCtD
Mepivacaine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00216	0.0034	CcSEcCtD
Mepivacaine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00339	CcSEcCtD
Mepivacaine—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.00214	0.00337	CcSEcCtD
Mepivacaine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00214	0.00337	CcSEcCtD
Mepivacaine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00214	0.00337	CcSEcCtD
Mepivacaine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00212	0.00334	CcSEcCtD
Mepivacaine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00212	0.00334	CcSEcCtD
Mepivacaine—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	0.00211	0.00333	CcSEcCtD
Mepivacaine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00211	0.00333	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0021	0.0104	CbGpPWpGaD
Mepivacaine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00329	CcSEcCtD
Mepivacaine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00327	CcSEcCtD
Mepivacaine—Back pain—Vincristine—peripheral nervous system neoplasm	0.00206	0.00325	CcSEcCtD
Mepivacaine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00203	0.0032	CcSEcCtD
Mepivacaine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00202	0.00318	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.002	0.00993	CbGpPWpGaD
Mepivacaine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00313	CcSEcCtD
Mepivacaine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00196	0.00309	CcSEcCtD
Mepivacaine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00195	0.00307	CcSEcCtD
Mepivacaine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00194	0.00306	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00193	0.00954	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00193	0.00954	CbGpPWpGaD
Mepivacaine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00302	CcSEcCtD
Mepivacaine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00301	CcSEcCtD
Mepivacaine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00191	0.00301	CcSEcCtD
Mepivacaine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.0019	0.00299	CcSEcCtD
Mepivacaine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00189	0.00298	CcSEcCtD
Mepivacaine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00189	0.00298	CcSEcCtD
Mepivacaine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00188	0.00297	CcSEcCtD
Mepivacaine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00188	0.00297	CcSEcCtD
Mepivacaine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00188	0.00297	CcSEcCtD
Mepivacaine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00296	CcSEcCtD
Mepivacaine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00187	0.00294	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00186	0.0092	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00186	0.0092	CbGpPWpGaD
Mepivacaine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00185	0.00291	CcSEcCtD
Mepivacaine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00184	0.0029	CcSEcCtD
Mepivacaine—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00183	0.00906	CbGpPWpGaD
Mepivacaine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00285	CcSEcCtD
Mepivacaine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00285	CcSEcCtD
Mepivacaine—Chills—Etoposide—peripheral nervous system neoplasm	0.00178	0.00281	CcSEcCtD
Mepivacaine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00178	0.0028	CcSEcCtD
Mepivacaine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.0028	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00177	0.00878	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00177	0.00279	CcSEcCtD
Mepivacaine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00278	CcSEcCtD
Mepivacaine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00278	CcSEcCtD
Mepivacaine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00175	0.00277	CcSEcCtD
Mepivacaine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00175	0.00277	CcSEcCtD
Mepivacaine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00275	CcSEcCtD
Mepivacaine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00174	0.00274	CcSEcCtD
Mepivacaine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00174	0.00274	CcSEcCtD
Mepivacaine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00173	0.00273	CcSEcCtD
Mepivacaine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00172	0.00272	CcSEcCtD
Mepivacaine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00171	0.00269	CcSEcCtD
Mepivacaine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00171	0.00269	CcSEcCtD
Mepivacaine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0017	0.00268	CcSEcCtD
Mepivacaine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00169	0.00266	CcSEcCtD
Mepivacaine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00266	CcSEcCtD
Mepivacaine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00266	CcSEcCtD
Mepivacaine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00266	CcSEcCtD
Mepivacaine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00168	0.00265	CcSEcCtD
Mepivacaine—Back pain—Etoposide—peripheral nervous system neoplasm	0.00167	0.00263	CcSEcCtD
Mepivacaine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00166	0.00262	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00262	CcSEcCtD
Mepivacaine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00257	CcSEcCtD
Mepivacaine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00163	0.00256	CcSEcCtD
Mepivacaine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.00256	CcSEcCtD
Mepivacaine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.00253	CcSEcCtD
Mepivacaine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.0016	0.00252	CcSEcCtD
Mepivacaine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00159	0.0025	CcSEcCtD
Mepivacaine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00248	CcSEcCtD
Mepivacaine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00248	CcSEcCtD
Mepivacaine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00156	0.00246	CcSEcCtD
Mepivacaine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00154	0.00243	CcSEcCtD
Mepivacaine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00242	CcSEcCtD
Mepivacaine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00242	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00242	CcSEcCtD
Mepivacaine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00241	CcSEcCtD
Mepivacaine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00153	0.00241	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00152	0.00239	CcSEcCtD
Mepivacaine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00151	0.00239	CcSEcCtD
Mepivacaine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00151	0.00239	CcSEcCtD
Mepivacaine—Headache—Topotecan—peripheral nervous system neoplasm	0.0015	0.00237	CcSEcCtD
Mepivacaine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00237	CcSEcCtD
Mepivacaine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.0015	0.00236	CcSEcCtD
Mepivacaine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00149	0.00236	CcSEcCtD
Mepivacaine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00149	0.00235	CcSEcCtD
Mepivacaine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00149	0.00235	CcSEcCtD
Mepivacaine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00149	0.00235	CcSEcCtD
Mepivacaine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00149	0.00234	CcSEcCtD
Mepivacaine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00227	CcSEcCtD
Mepivacaine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00143	0.00226	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00143	0.0071	CbGpPWpGaD
Mepivacaine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00226	CcSEcCtD
Mepivacaine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00225	CcSEcCtD
Mepivacaine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00143	0.00225	CcSEcCtD
Mepivacaine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00141	0.00223	CcSEcCtD
Mepivacaine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00141	0.00223	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00223	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00141	0.00222	CcSEcCtD
Mepivacaine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.0022	CcSEcCtD
Mepivacaine—Nausea—Melphalan—peripheral nervous system neoplasm	0.0014	0.0022	CcSEcCtD
Mepivacaine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00138	0.00218	CcSEcCtD
Mepivacaine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00138	0.00217	CcSEcCtD
Mepivacaine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00137	0.00217	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00137	0.0068	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00136	0.00675	CbGpPWpGaD
Mepivacaine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00136	0.00215	CcSEcCtD
Mepivacaine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.0021	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00132	0.00653	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00132	0.00653	CbGpPWpGaD
Mepivacaine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00132	0.00208	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00131	0.00647	CbGpPWpGaD
Mepivacaine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00204	CcSEcCtD
Mepivacaine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00128	0.00202	CcSEcCtD
Mepivacaine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00201	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00127	0.0063	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00127	0.0063	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00127	0.00627	CbGpPWpGaD
Mepivacaine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00127	0.00199	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00125	0.00197	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00125	0.00619	CbGpPWpGaD
Mepivacaine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00125	0.00197	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00195	CcSEcCtD
Mepivacaine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.00195	CcSEcCtD
Mepivacaine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00192	CcSEcCtD
Mepivacaine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00188	CcSEcCtD
Mepivacaine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00187	CcSEcCtD
Mepivacaine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00116	0.00182	CcSEcCtD
Mepivacaine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00115	0.00181	CcSEcCtD
Mepivacaine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00181	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00181	CcSEcCtD
Mepivacaine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00179	CcSEcCtD
Mepivacaine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00178	CcSEcCtD
Mepivacaine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00178	CcSEcCtD
Mepivacaine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00112	0.00176	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00111	0.00176	CcSEcCtD
Mepivacaine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00111	0.00174	CcSEcCtD
Mepivacaine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00174	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00173	CcSEcCtD
Mepivacaine—Headache—Vincristine—peripheral nervous system neoplasm	0.00109	0.00172	CcSEcCtD
Mepivacaine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00169	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00165	CcSEcCtD
Mepivacaine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00104	0.00164	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00163	CcSEcCtD
Mepivacaine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00103	0.00163	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00102	0.00507	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00102	0.00504	CbGpPWpGaD
Mepivacaine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00101	0.00159	CcSEcCtD
Mepivacaine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000997	0.00157	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000997	0.00157	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000979	0.00485	CbGpPWpGaD
Mepivacaine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000978	0.00154	CcSEcCtD
Mepivacaine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000968	0.00153	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000959	0.00151	CcSEcCtD
Mepivacaine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00095	0.0015	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00094	0.00466	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00094	0.00466	CbGpPWpGaD
Mepivacaine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00094	0.00148	CcSEcCtD
Mepivacaine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000936	0.00148	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000932	0.00147	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000923	0.00146	CcSEcCtD
Mepivacaine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000914	0.00144	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000912	0.00144	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000907	0.00449	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000907	0.00449	CbGpPWpGaD
Mepivacaine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000896	0.00141	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000895	0.00141	CcSEcCtD
Mepivacaine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000893	0.00443	CbGpPWpGaD
Mepivacaine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000889	0.0014	CcSEcCtD
Mepivacaine—Headache—Etoposide—peripheral nervous system neoplasm	0.000883	0.00139	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000879	0.00139	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00087	0.00137	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000868	0.00137	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000866	0.00137	CcSEcCtD
Mepivacaine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000851	0.00134	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—MET—peripheral nervous system neoplasm	0.000847	0.0042	CbGpPWpGaD
Mepivacaine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000844	0.00133	CcSEcCtD
Mepivacaine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000838	0.00132	CcSEcCtD
Mepivacaine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000837	0.00132	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000836	0.00132	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000823	0.0013	CcSEcCtD
Mepivacaine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000821	0.00129	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000803	0.00127	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00079	0.00125	CcSEcCtD
Mepivacaine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00079	0.00125	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.00124	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000784	0.00388	CbGpPWpGaD
Mepivacaine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000777	0.00123	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.00122	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000773	0.00122	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000771	0.00122	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000764	0.0012	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00076	0.0012	CcSEcCtD
Mepivacaine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000738	0.00116	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.00115	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.00115	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000719	0.00113	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000713	0.00112	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000709	0.00112	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.00111	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000702	0.00111	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.000685	0.0034	CbGpPWpGaD
Mepivacaine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.00108	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000656	0.00103	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	0.000656	0.00325	CbGpPWpGaD
Mepivacaine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00065	0.00102	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000637	0.00316	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000634	0.00314	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.00063	0.00312	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.00063	0.00312	CbGpPWpGaD
Mepivacaine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000627	0.000989	CcSEcCtD
Mepivacaine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000984	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000619	0.00307	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000607	0.00301	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000607	0.00301	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000606	0.003	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000605	0.003	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000582	0.00289	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000582	0.00289	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000917	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.000915	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000911	CcSEcCtD
Mepivacaine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000893	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000562	0.00278	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000562	0.00278	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000559	0.00277	CbGpPWpGaD
Mepivacaine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000559	0.000881	CcSEcCtD
Mepivacaine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000849	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000827	CcSEcCtD
Mepivacaine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000522	0.000823	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.000815	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000508	0.00252	CbGpPWpGaD
Mepivacaine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000792	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000501	0.00248	CbGpPWpGaD
Mepivacaine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000495	0.00078	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000489	0.00242	CbGpPWpGaD
Mepivacaine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000762	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000479	0.00237	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000471	0.00233	CbGpPWpGaD
Mepivacaine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000469	0.00074	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000468	0.00232	CbGpPWpGaD
Mepivacaine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000733	CcSEcCtD
Mepivacaine—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00046	0.00228	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00046	0.00228	CbGpPWpGaD
Mepivacaine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000722	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000452	0.00224	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000449	0.00223	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000449	0.00223	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000444	0.0022	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000444	0.0022	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000442	0.00219	CbGpPWpGaD
Mepivacaine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000684	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000433	0.00215	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000433	0.00215	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000433	0.00214	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000427	0.00212	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000416	0.00206	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000416	0.00206	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000401	0.00199	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000401	0.00199	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000395	0.00196	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000381	0.00189	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000365	0.00181	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000357	0.00177	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00035	0.00174	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00035	0.00174	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000345	0.00171	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000342	0.00169	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000338	0.00167	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000338	0.00167	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000336	0.00167	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000328	0.00163	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000328	0.00163	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000317	0.00157	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000317	0.00157	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000312	0.00155	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000305	0.00151	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000282	0.0014	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000279	0.00138	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000272	0.00135	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000267	0.00132	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00026	0.00129	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000256	0.00127	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000256	0.00127	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00025	0.00124	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00025	0.00124	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000247	0.00122	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000247	0.00122	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000246	0.00122	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000241	0.00119	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000241	0.00119	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000237	0.00118	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000223	0.0011	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000217	0.00108	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000199	0.000986	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00019	0.000943	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000183	0.000906	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000183	0.000906	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000176	0.000873	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000176	0.000873	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000176	0.00087	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000174	0.00086	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000169	0.000839	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000168	0.000832	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000161	0.0008	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000161	0.0008	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000156	0.000771	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000156	0.000771	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000124	0.000614	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000109	0.000542	CbGpPWpGaD
